Treatment of Female Sexual Dysfunction Due to Dyspareunia with Solid-State Vaginal Laser and Recombinant Platelet-Derived Epidermal Growth Factors: A Viable Possibility?
Objective: To examine the efficacy and safety of non-pharmacological and non-ablative options (or a combination of these) for postmenopausal dyspareunia. Mechanism: Narrative review on non-pharmacological and non-ablative options (or a combination of these) for postmenopausal dyspareunia. Findings i...
Saved in:
Main Authors: | Nicolas Mendoza (Author), Francisco Quereda (Author) |
---|---|
Format: | Book |
Published: |
IMR Press,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pathogenesis of dyspareunia associated with pelvic floor dysfunction: A review
by: Elena S. Silantyeva, et al.
Published: (2023) -
Treating dyspareunia caused by vaginal atrophy: a review of treatment options using vaginal estrogen therapy
by: SA Kingsberg, et al.
Published: (2009) -
The impact of Date Palm Pollen Capsule on Vaginal Iubrication and Dyspareunia In Menopausal Woman
by: Somayeh Sadeghi Goghari, et al.
Published: (2018) -
Risk factors of dyspareunia associated with the pelvic floor dysfunction: perspective on the issue
by: Mekan R. Orazov, et al.
Published: (2023) -
Dyspareunia caused by a vaginal adhesion band following a transvaginal mesh repair
by: Cheng-Yu Long, et al.
Published: (2013)